Release Date: 01/08/16 08:11 Summary: Quarterly Activities Report & Appendix 4C-TV2.AX Price Sensitive: Yes Download Document 166.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%